HYMC ISRAEL - Hillel Yaffe Medical Center’s Post

🚨Revolutionary Watchman Flex Device: A Game-Changer in Cardiac Monitoring The Watchman Flex Device, is a groundbreaking medical device designed to reduce the risk of stroke in patients with non-valvular atrial fibrillation (AFib). 💁How it Works The Watchman Flex Device is a small, umbrella-shaped implant that is inserted through a minimally invasive procedure. It is designed to block blood clots from forming in the left atrial appendage (LAA), a common source of stroke-causing clots in AFib patients. 🙆Key Benefits 1. Reduced Stroke Risk: The Watchman Flex Device has been shown to reduce the risk of stroke by up to 80% in AFib patients. 2. Minimally Invasive: The implantation procedure is minimally invasive, reducing recovery time and scarring. 3. Permanent Solution: The Watchman Flex Device is a permanent solution, eliminating the need for long-term anticoagulation therapy. 1. Watchman Flex Device 2. Cardiac monitoring 3. Atrial fibrillation 4. Stroke prevention 5. Minimally invasive procedure 6. Boston Scientific #WatchmanFlexDevice #Cardiology #AtrialFibrillation #StrokePrevention #MedicalDeviceInnovation Share your thoughts on the Watchman Flex Device! How do you see this technology impacting the future of cardiac care?

Boston Scientific has achieved a significant milestone in cardiac care with FDA approval for its Farawave Nav Ablation Catheter and clearance for the Faraview Software. These technologies are designed to enhance visualization during cardiac ablation procedures using the Farapulse Pulsed Field Ablation (PFA) System. The Farawave Nav Catheter builds upon the existing Farawave catheter by adding magnetic navigation capabilities, allowing for cardiac mapping and PFA therapy delivery within a single integrated catheter while minimizing the need for additional device exchanges. The Faraview Software offers a dynamic view of catheter placement, shape, and rotation, along with magnetic tracking of the Farawave Nav Catheter, enabling physicians to visualize cumulative therapy delivery to guide their ablation strategy. Dr. Vivek Reddy, director of electrophysiology at Mount Sinai Fuster Heart Hospital, noted that in clinical use, these technologies produced detailed cardiac maps that could improve guidance, limit fluoroscopy times, and assist physicians in assessing energy delivery locations during PFA procedures. Boston Scientific plans to immediately launch the Farawave Nav Ablation Catheter and Faraview Software in the U.S. This launch is expected to provide physicians with advanced tools for treating paroxysmal atrial fibrillation, potentially improving patient outcomes and procedural efficiency. https://lnkd.in/ecbkcvn9 📰 Stay ahead in healthcare by following Practical Patient Care on LinkedIn! Get the latest news and insights on patient care and clinical advancements. Join our community to stay informed and enhance your knowledge. Follow us today! #PracticalPatientCare #BostonScientific #CardiacCare #AtrialFibrillation #MedicalInnovation

Behind every successful interventional cardiology procedure is a dedicated team working under high-pressure conditions and managing radiation exposure. Learn how advanced technology, innovative protective gear, and teamwork are shaping the future of healthcare. Read the full article: https://buff.ly/40zp7iH #InterventionalCardiology #HealthcareInnovation #RadiationSafety

Abbott has officially launched its pioneering AVEIR dual chamber (DR) leadless pacemaker system in the UK, marking a major milestone in cardiac care. This ground-breaking technology, the first of its kind worldwide, is designed to treat patients with abnormal or slow heart rhythms through a minimally invasive procedure. With over 2 million people in the UK affected by arrhythmias, and 80% of pacemaker recipients requiring a dual chamber device, Abbott’s innovation offers a transformative solution. For the first time, two leadless pacemakers can communicate with each other, synchronising the atrial and ventricular chambers of the heart. Using Abbott’s proprietary i2i™ technology, the pacemakers deliver real-time, beat-to-beat communication, reducing the risks associated with traditional pacemakers and improving patient outcomes. This breakthrough minimises recovery times and provides a less restrictive, more advanced treatment option for those in need of dual chamber pacing. Professor Tom Wong, consultant cardiologist at Royal Brompton & Harefield Hospitals, called the technology a "major leap forward", while Ross Campbell, Abbott’s General Manager for Cardiac Rhythm Management in the UK & Ireland, emphasised its potential to transform care for patients with irregular heart rhythms. https://lnkd.in/eXktGpfh #MedTech #Cardiology #Abbott #Pacemaker #Healthcare #UK

#OPNNC Super-High–Pressure Device CTO toolbox: Special Balloons By Matteo Maurina and Valeria Paradies. Many thanks to you. Three key take aways: 1. #designed specifically to treat highly calcified and/or nondilatable lesions, as well useful for treating ISR and is used for stent postdilatation and/or to correct malapposition and underexpansion 2. #safety remarkable resistance to high pressure inflation due to its dual-layer construction, should be used with the dedicated SIS Medical inflators 3. #performance reported super-high-pressure burst of 35 atm, the linear compliance curve stays flat even at extremely high pressure Summary: An important instrument in the interventional cardiology toolbox for handling complex coronary lesions. #OPNNC #SuperHighPressure #SISMedical

A comprehensive OPO cath lab report gives transplant surgeons the confidence to make decisions quickly and confidently, which can lead to more successful heart transplants. Check out Part One of our two-part blog series on heart caths and donor management, we break down the key elements of an OPO cath lab report, starting with cardiac catheterization. https://lnkd.in/gjHSzv8S #OrganDonation #TeleDiagnostics #TransplantProfessional

Despite the critical role of diagnostic ECG across specialties, there are persistent shortcomings in ECG training starting in medical school, which may ultimately result in suboptimal accuracy and poorer patient care. #ePeeps #DCARInsights #cardiology #CardioTwitter

Despite the critical role of diagnostic ECG across specialties, there are persistent shortcomings in ECG training starting in medical school, which may ultimately result in suboptimal accuracy and poorer patient care. #ePeeps #DCARInsights #cardiology #CardioTwitter

Acute myocardial infarction (AMI), a critical medical emergency, occurs due to partial or complete blockage of the coronary arteries, which supply blood to the heart. This blockage, if untreated, can cause irreversible heart cell damage. Consequently, rapid and precise intervention is essential to mitigate harm. A notable advancement in AMI treatment is robotic percutaneous angioplasty. This cutting-edge technique allows blocked coronary arteries to be reopened with millimetric precision, enhancing safety for both patients and operators. At the forefront of this innovation, the Clinical, Interventional, and Coronary Intensive Care Unit (UTIC) at IRCCS Policlinico San Donato, led by Dr. Francesco Bedogni, has adopted this approach, highlighting its potential to reduce risks and Policlinico San Donato, a prominent cardiology center, has invested in Robocath, an advanced robotic system that enables cardiologists to perform percutaneous angioplasty accurately and safely. Its 24-hour cath centers ensure specialists are available to start angioplasty within 20 minutes of an emergency call—a process that previously relied on complex manual techniques. The robotic platform improves patient outcomes and allows operators to control the procedure outside the operating room, ensuring their safety and minimizing radiation exposure. Currently, the R-One+ robotic platform, or Robocath, is the only available system for robotic percutaneous angioplasty, with IRCCS Policlinico San Donato being the sole center in Italy equipped with it. The benefits of robotic technology in interventional cardiology include: 1. Precision: The ability to move equipment in millimeter increments allows for the exact placement of stents unaffected by the patient’s movements. 2. Physician Comfort: The operator no longer needs to wear heavy lead aprons for X-ray protection when working outside the operating room, which improves focus and facilitates easy access to patient data, especially during emergencies. 3. Potential for Remote Operations: Still under development, this aspect of telemedicine could allow specialists to perform angioplasties remotely. #hospitals #innovation #doh #research #Robotic

Did you know… A catheterisation laboratory or ‘cath lab’ is a cross between a surgical theatre and a x-ray room. A moveable x-ray machine and multiple screens around the room allow diagnostic imaging during the procedure. A cath lab can be used for a wide variety of tests and procedures, such as cardiac ablation, angiogram, angioplasty as well as implantation of pacemakers or implantable cardioverter defibrillator (ICD). During the procedure, your cardiologist makes a small incision in either your arm or groin and insert a tiny tube, also known as catheter, into your blood vessel and then into your coronary arteries. The main benefit of a cath lab is that procedures don’t require creating a large incision to open up the chest or to give access to your heart. This means that you can recover quicker and are at much smaller risk of developing complications. If you have any concerns about your heart health, book an appointment with one of our cardiologists at https://lnkd.in/dbEzidiU or give us a call at 020 3386 9000 #NuffieldHealth #cathlab #catheter #CardiologyCare #HeartHealth